Exact Sciences
EXAS
#1921
Rank
S$11.34 B
Marketcap
$61.07
Share price
-3.02%
Change (1 day)
-28.84%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -S$1.38 Billion

According to Exact Sciences's latest financial reports the company's current earnings are S$2.75 Billion. a decrease over its 2023 earnings that were of -S$0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 -S$1.36 Billion435.08%
2023 -S$0.26 Billion-69.28%
2022 -S$0.83 Billion-25.55%
2021 -S$1.11 Billion1.68%
2020 -S$1.1 Billion271.17%
2019 -S$0.3 Billion58.99%
2018 -S$0.19 Billion20.89%
2017 -S$0.16 Billion-30.95%
2016 -S$0.23 Billion5.09%
2015 -S$0.22 Billion57.24%
2014 -S$0.14 Billion116.53%
2013 -S$61.91 Million
2011 -S$38.54 Million143.73%
2010 -S$15.82 Million27.85%
2009 -S$12.37 Million0.27%
2008 -S$12.34 Million-20.95%
2007 -S$15.61 Million-13.53%
2006 -S$18.05 Million-10.07%
2005 -S$20.07 Million-21.81%
2004 -S$25.67 Million-33.44%
2003 -S$38.56 Million-6.51%
2002 -S$41.25 Million17.95%
2001 -S$34.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.17 Billion-88.12%๐Ÿ‡บ๐Ÿ‡ธ USA
S$88.09 M-106.49%๐Ÿ‡บ๐Ÿ‡ธ USA
S$34.42 M-102.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$46.76 Million-96.56%๐Ÿ‡บ๐Ÿ‡ธ USA
S$10.61 B-882.10%๐Ÿ‡ซ๐Ÿ‡ท France